Use of Win Statistics to Analyze Outcomes in the DAPA-HF and DELIVER Trials

Authors:

Abstract
Win Statistics in HF TrialsIn this study, we applied win statistics to the DAPA-HF and DELIVER trials, exploring the effect of dapagliflozin on a composite outcome incorporating patient-reported outcomes as well as total heart failure events and cardiovascular deaths.

This publication has 40 references indexed in Scilit: